Related Experiment Video
Updated: Jan 4, 2026

Whole-body PET/MRI of Pediatric Patients: The Details That Matter
Published on: December 19, 2017
Ferumoxytol-enhanced MRI in patients with prior cardiac transplantation
Colin G Stirrat1, Shirjel Alam2, Thomas J MacGillivray3
1Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK.
Objectives:
Ultra-small superparamagnetic particles of iron oxide (USPIO)-enhanced MRI can detect cellular inflammation within tissues and may help non-invasively identify cardiac transplant rejection. Here, we aimed to determine the normal reference values for USPIO-enhanced MRI in patients with a prior cardiac transplant and examine whether USPIO-enhanced MRI could detect myocardial inflammation in patients with transplant rejection.
Methods:
Ten volunteers and 11 patients with cardiac transplant underwent T2, T2* and late gadolinium enhancement 1.5T MRI, with further T2* imaging at 24 hours after USPIO (ferumoxytol, 4 mg/kg) infusion, at baseline and 3 months.
Results:
Ten patients with clinically stable cardiac transplantation were retained for analysis. Myocardial T2 values were higher in patients with cardiac transplant versus healthy volunteers (53.8±5.2 vs 48.6±1.9 ms, respectively; p=0.003). There were no differences in the magnitude of USPIO-induced change in R2* in patients with transplantation (change in R2*, 26.6±7.3 vs 22.0±10.4 s-1 in healthy volunteers; p=0.28). After 3 months, patients with transplantation (n=5) had unaltered T2 values (52.7±2.8 vs 52.12±3.4 ms; p=0.80) and changes in R2* following USPIO (29.42±8.14 vs 25.8±7.8 s-1; p=0.43).
Conclusion:
Stable patients with cardiac transplantation have increased myocardial T2 values, consistent with resting myocardial oedema or fibrosis. In contrast, USPIO-enhanced MRI is normal and stable over time suggesting the absence of chronic macrophage-driven cellular inflammation. It remains to be determined whether USPIO-enhanced MRI may be able to identify acute cardiac transplant rejection.
Trial Registration Number:
NCT02319278349 (https://clinicaltrials.gov/ct2/show/NCT02319278) Registered 03.12.2014 EUDraCT 2013-002336-24.
Insights
Ultra-small superparamagnetic particles of iron oxide (USPIO)-enhanced MRI shows higher myocardial T2 values in stable cardiac transplant patients, suggesting edema or fibrosis. USPIO-enhanced MRI appears normal, indicating no chronic inflammation, but its role in acute rejection needs further study.
Area of Science:
- Cardiovascular Imaging
- Biomedical Engineering
- Radiology
Background:
- Cardiac transplant rejection can be identified non-invasively using ultra-small superparamagnetic particles of iron oxide (USPIO)-enhanced MRI.
- USPIO-enhanced MRI detects cellular inflammation within tissues.
Purpose of the Study:
- Determine normal reference values for USPIO-enhanced MRI in cardiac transplant patients.
- Examine USPIO-enhanced MRI's ability to detect myocardial inflammation in transplant rejection.
Main Methods:
- 1.5T MRI including T2, T2*, and late gadolinium enhancement was performed on 10 volunteers and 11 cardiac transplant patients.
- T2* imaging was repeated 24 hours post-USPIO (ferumoxytol) infusion at baseline and 3 months.
Main Results:
- Stable cardiac transplant patients exhibited higher myocardial T2 values (53.8±5.2 ms) compared to healthy volunteers (48.6±1.9 ms; p=0.003).
- No significant differences were observed in USPIO-induced R2* change between transplant patients and controls (26.6±7.3 vs 22.0±10.4 s⁻¹; p=0.28).
- T2 values and USPIO-induced R2* changes remained stable at 3-month follow-up in transplant patients.
Conclusions:
- Stable cardiac transplant patients show increased myocardial T2 values, potentially indicating edema or fibrosis.
- USPIO-enhanced MRI appears normal and stable, suggesting an absence of chronic macrophage-driven inflammation.
- Further research is needed to determine if USPIO-enhanced MRI can detect acute cardiac transplant rejection.
More Related Videos
06:29Cardiac Magnetic Resonance for the Evaluation of Suspected Cardiac Thrombus: Conventional and Emerging Techniques
Published on: June 11, 2019
08:13In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography
Published on: February 16, 2016
Related Concept Videos
Imaging Studies for Cardiovascular System IV: CMRI
Imaging Studies for Cardiovascular System V: CT
Imaging Studies I: CT and MRI
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...
Magnetic Resonance Imaging
Imaging Studies IV: Magnetic Resonance Imaging